Keio University · 의학
유와미노 요시후미 교수의 연구실은 감염병 진단 기술 개발에 초점을 맞추고 있으며, 특히 RT-PCR 기반의 빠르고 정확한 바이러스 및 미생물 진단 방법을 연구하고 있습니다. saliva를 이용한 SARS-CoV-2 진단, 비결핵성 항산균 감염의 유병률 분석, 그리고 결핵 및 비결핵성 항산균을 동시에 진단할 수 있는 신속 진단 테스트(Myco-Panel) 개발이 주요 연구 과제입니다. 또한, 샘플 보관 중 RNA 분해를 막기 위한 생물학적 고려사항도 함께 고려하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
COVID-19 prevalence has increased worldwide. Reverse transcription (RT)-PCR-based SARS-CoV-2 detection has majorly contributed to COVID-19 diagnosis. Although nasopharyngeal swab samples are commonly used for RT-PCR, infection risk is high among the healthcare personnel during sample collection. Saliva, which can be self-collected by patients even at home, has been proposed as a sample for RT-PCR-based SARS-CoV-2 detection, thus potentially reducing the infection risk among healthcare personnel.
Low serum E2 levels were strongly related to MAC-LD in postmenopausal women.
Our results show that H. cinaedi infections are quite common in immunocompetent community-dwelling individuals.
The prevalence of nontuberculous mycobacterial diseases is increasing worldwide, and tuberculosis remains highly prevalent. Rapid and accurate microbial diagnoses of both tuberculosis and nontuberculous mycobacterial infections are required. A novel PCR-reverse sequence-specific oligonucleotide probe (PCR-rSSO) method-based mycobacterial detection panel (Myco-Panel) test was developed for the rapid identification of 30 mycobacterial species and subspecies. Clinical respiratory samples were colle
